Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
BioAtlantis specializes in the extraction of natural bioactive compounds from renewable marine and terrestrial resources—primarily seaweed—to develop biostimulant solutions for crops as well as nutraceuticals targeting immunity and metabolic health for animals and humans. The company’s products are scientifically validated through academic collaborations. Its agricultural biostimulant portfolio addresses abiotic stresses such as drought or salinity; its animal health solutions modulate immunity/microbiome; its first human-targeted product line focuses on metabolic disease with Digestica®. The company operates the largest seaweed extraction facility in Britain/Ireland.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on BioAtlantis.